Infliximab biosimilar CT-P13 in Crohn's disease

Research output: Contribution to journal › Comment/Letter to the editor › Academic

2 Citations (Scopus)

Access to Document

@article{d73a7f8d81734368b02901365e885ed1,

title = "Infliximab biosimilar CT-P13 in Crohn's disease",

author = "Gecse, {Krisztina B.} and D'Haens, {Geert R.}",

year = "2019",

month = apr,

day = "27",

doi = "https://doi.org/10.1016/S0140-6736(18)32778-8",

language = "English",

volume = "393",

pages = "1671--1672",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10182",

}

TY - JOUR

T1 - Infliximab biosimilar CT-P13 in Crohn's disease

AU - Gecse, Krisztina B.

AU - D'Haens, Geert R.

PY - 2019/4/27

Y1 - 2019/4/27

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064588827&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30929894

U2 - https://doi.org/10.1016/S0140-6736(18)32778-8

DO - https://doi.org/10.1016/S0140-6736(18)32778-8

M3 - Comment/Letter to the editor

C2 - 30929894

SN - 0140-6736

VL - 393

SP - 1671

EP - 1672

JO - Lancet

JF - Lancet

IS - 10182

ER -